# BLGSP Continuation

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2021 · $535,340

## Abstract

This project provides for the continued collection and genomic characterization and analysis for Burkitt Lymphoma cases under the Burkitt Lymphoma Genome Sequencing Project.

## Key facts

- **NIH application ID:** 10329756
- **Project number:** 75N91019D00024-P00003-759102000003-26
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** LEONARD FREEDMAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $535,340
- **Award type:** —
- **Project period:** 2020-08-31 → 2021-08-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10329756

## Citation

> US National Institutes of Health, RePORTER application 10329756, BLGSP Continuation (75N91019D00024-P00003-759102000003-26). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10329756. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*